Insulet Corporation
PODDNASDAQHealthcareMedical Devices
As of Oct 16, 2026 close
- Market cap
- $9.63B
- P/E (TTM)
- 25.66
- Forward P/E
- 16.34
- Dividend yield
- -
- 52-week range
- $126.40$354.88
- Volume (live)
- -
- Avg. volume (3M)
- 1.61M
Insulet (PODD) Stock Price & Financial Analysis
Insulet Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $140.22 - $143.31 |
|---|---|
| 52-Week High | $354.88 |
| 52-Week Low | $126.40 |
| Open | $140.46 |
| Volume (last close) | 1.62M |
| Average Volume (3M) | 1.61M |
| Revenue (TTM) | 3.05B |
|---|---|
| Net Income (TTM) | 375.30M |
| Free Cash Flow (TTM) | 288.20M |
| EPS (TTM) | $5.34 |
| Profit Margin | 12.29% |
| Operating Margin | 16.89% |
| Return on Equity (ROE) | 26.39% |
| Debt to Equity | 0.67 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 9.63B |
|---|---|
| Shares Outstanding | 69.40M |
| P/E Ratio (TTM) | 25.66 |
| Forward P/E | 16.34 |
| Price to Sales (P/S) | 3.15 |
| Price to Book (P/B) | 6.77 |
| EV/EBITDA | 15.77 |
| 50-Day MA | $140.28 |
|---|---|
| 200-Day MA | $187.23 |
| 1-Year Change | −56.44% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Insulet at a Glance
As of the Oct 16, 2026 close, Insulet (PODD) has a market capitalization of $9.63B. The stock trades at 25.7× trailing earnings, 16.3× forward earnings and 3.1× sales. Over the trailing twelve months it earned $375.30M on revenue of $3.05B (a 12.3% profit margin) and generated $288.20M of free cash flow. Revenue grew 29.4% year over year.
As of its latest reported balance sheet, it holds $534.90M in cash and securities against $948.40M of debt, a net debt position of $413.50M.
Insulet does not currently pay a dividend.
The share price is down 56.4% over the past year. At $141.10 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $126.40 to $354.88, below its 200-day moving average of $187.23.
Based on 19 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $164.43, 16.5% above the Oct 16, 2026 close.
Frequently Asked Questions About Insulet
What is the current stock price for PODD?
As of the Oct 16, 2026 close, PODD stock trades at $141.10. The 52-week range is $126.40–$354.88, with a day range of $140.22–$143.31.
What is the P/E ratio for PODD?
As of the Oct 16, 2026 close, Insulet's trailing twelve-month (TTM) P/E ratio is 25.7, meaning investors pay $25.7 for every $1 of annual earnings. The forward P/E is 16.3, reflecting analyst expectations for future earnings. Insulet operates in the Healthcare sector.
Does PODD pay dividends?
Insulet does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for PODD?
Based on ratings from 19 professional analysts over the last 90 days, the consensus for PODD is Hold. The average 12-month price target is $164.43, a 16.5% upside from the Oct 16, 2026 close of $141.10.
What is the market cap of PODD?
As of the Oct 16, 2026 close, Insulet's market capitalization is $9.79B, classifying it as a mid-cap company. Insulet operates in the Healthcare sector within the Medical Devices industry.